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Measles virus (MV), one of the most infectious of human pathogens, still infects over 30 million humans and causes over 500,000 deaths each
year [Griffin, D., 2001. Measles virus. In: Fields, B., Knipe, D., Howley, P. (Eds.), Fields Virology. Lippincott-Raven, Philadelphia, pp. 1401–
1442; MMWR, 2005. Progress in reducing measles mortality–worldwide, 1999–2003. Morb. Mortal. Wkly Rep. 54, 200–203]. Death is
primarily due to secondary microbial infections associated with the immunosuppression caused by MV. Studies of humans with genetic or
acquired deficiencies of either the humoral or cellular arm of the immune system, and rodent models have implicated T cells in the control of the
ongoing MV infection but the precise role and activities of the specific T cell subset or the molecules they produce is not clear. Using a transgenic
mouse model in conjunction with depletion and reconstitution of individual B and T cell subsets alone or in combination, we show that neither
CD4, CD8 nor B cells per se control acute MV infection. However, combinations of either CD4 T cells and B cells, or of CD4 and CD8 T cells are
essential but CD8 Twith B cells are ineffective. Interferon-γ and neutralizing antibodies, but neither perforin nor TNF-α alone are associated with
clearance of MV infection. TNF-α combined with interferon-γ is more effective in protection than interferon alone. Further, the lack of an
interferon-γ response leads to persistence of MV.
© 2006 Elsevier Inc. All rights reserved.Keywords: Persistent infection; Measles virus; CD4 T cells; Interferon-gamma; Immune clearanceIntroduction
Measles virus (MV) infection is most often self limited,
causing an acute febrile illness with rash. Humoral (antibody)
and cell-mediated (T cell) immune responses both act to restrict
MV infection, although T cells appear to be the major player
(Burnet, 1968; Good and Zak, 1956; Whitton and Oldstone,
2001). The evidence for T cells predominant role is, first, that
children with Bruton's sex-linked a-gammaglobulinemia be-
come infected with MV but despite the absence of antibodies
display normal kinetics for full recovery and are immune to⁎ Corresponding author. Fax: +1 858 784 9981.
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doi:10.1016/j.virol.2006.01.050subsequent MV exposure (reinfection) (Good and Zak, 1956;
Nahmias et al., 1967; Whitton and Oldstone, 2001). Second,
children without functional T cells either because of a genetic
defect or acquired through T cell leukemia/lymphoma or AIDS
often do not control MV infection, even after infusion of MV
hyperimmunoglobulin (Katz, 1998; Whitton and Oldstone,
2001). Frequently, such T cell deficient individuals develop
fatal giant cell pneumonia (Burnet, 1968). Yet, antibody therapy
given shortly after MV infection modulates, in part, the clinical
illness and reduce its severity (Griffin, 2001; Katz, 1998)
indicating some role for this reagent.
The genetic and acquired T cell deficiencies involve both
CD4 and CD8 T cell. In some viral infections, CD8 T cells can
act alone in overcoming an acute virus infection, but in others,
CD8 T cells rely on CD4 T cell help for their maintenance and
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T cells also help B cells make antibody (reviewed (Dhib-Jalbut
and Jacobson, 1994; Paul, 1989; UytdeHaag et al., 1994;
Weidinger et al., 2000; Whitton and Oldstone, 2001). Thus, the
dilemma is determining the specific T lymphocyte populations
alone or in combination with each other or with B cells as well as
the products theymake, i.e., IFN-γ, TNF-α, perforin (Kagi et al.,
1995; Matloubian et al., 1994; Slifka et al., 2003; Tishon et al.,
1995;Walsh et al., 1994), play in control of MV infection (Slifka
et al., 2003; Weidinger et al., 2000).
To address this issue, we humanized mice with the MV
receptor CD46 (Oldstone et al., 1999) and bred such mice to
Rag1−/− mice to ensure their depletion of T and B cells (Alt et
al., 1992). CD46+ ×Rag1−/−mice when infected intracerebrally
(i.c.) with MV routinely succumb to infection by 48 ± 4 days
(Oldstone et al., 2005; Patterson et al., 2001) unless reconstituted
with syngeneic splenic lymphocytes, in which case they are
totally protected.
We report here that deletion and reconstitution of single
lymphocyte components or with mixtures of lymphocyte
subsets indicated that robust clearance of MV occurred only
when CD4 Tcells were used in combination with B cells or with
CD8 T cells. Transfer of CD4 T cells with B cells into
CD46+ × Rag1−/− mice protected recipients from the expected
lethality associated with unrestricted MV replication in the
brain. These mice received no CD8 T cells and made high titers
of neutralizing antibodies. Other CD46+ × Rag1−/− animals
controlled MV infection when adoptively transferred with a
combination of CD4 with CD8 T cells. Protection occurred in
the absence of neutralizing antibodies, but both IFN-γ and
TNF-α were made. When T cells adoptively transferred into
CD46+ × Rag1−/− mice were obtained from IFN-γ knockout
(ko) mice, immune protection from MV was incomplete,
indicating a dominant role for this cytokine in clearing MV from
the CNS. Interestingly, mice devoid of IFN-γ that survived
acute MV infection developed persistent CNS infection. In
contrast, when CD4 and CD8 T cells were obtained from either
TNF-α or perforin ko mice, all mice survived, and MV was
cleared indicating neither of these molecules alone played a
prominent role in control of virus.
Results
A transgenic model for study of MV immunity
MV is a human pathogen and, although the virus can be
adapted to replicate in rodents by using multiple forced
infected brain passages, the result is dramatic alterations in
viral sequence, receptor usage and cell tropism that differs
from the human infection (Liebert and Finke, 1995; Rima et
al., 1995). Mice lack the receptor for MV. To better mimic
human MV infection, we humanized mice utilizing transgenic
technology to express one of the MV receptors, CD46
(Oldstone et al., 1999) and inoculated these mice with MV.
We utilized the CD46 receptor instead of the other known MV
receptor, SLAM (Hsu et al., 2001; Ono et al., 2001; Tatsuo et
al., 2000) because we were studying control of MV infectionof the CNS and CD46 but not SLAM is expressed on neurons,
the primary cell infected in this tissue (Oldstone et al., 2002).
As shown in Fig. 1 (panel A), adult immunocompetent mice
(CD46+ × Rag1+/+) inoculated i.c. with 1 × 103 to
1 × 105 PFU of MV (data were similar for each dilution of
virus so results are shown for the 1 × 105 PFU dose which
was also used for all subsequent experiments), failed to
replicate MV in their brains. That is, Northern blotting did not
detect viral RNA nor did immunofluorescence detect viral
antigen. These mice did not develop clinical disease. In
contrast, when T and B cells were removed from CD46+ mice
(CD46+ × Rag1−/−) identically inoculated, all 20 recipients
died, within a mean death of 48 ± 4 days post-inoculation, and
all expressed MV RNA and protein. The typical clinical profile
of this illness appeared 2 to 4 days before death and progressed
from ruffled fur and lethargy to ataxia, kyphosis and paralysis.
When similar CD46+ × Rag−/− mice received adoptive
transfers of 5 or 1 × 107 spleen cells from C57Bl/6 (H-2b)
syngeneic mice (Fig. 1, panels B and C), but not 5 × 106
splenic lymphocytes given 3 days before or 3 or 10 days after
MV inoculation (Fig. 1, panel D), all mice survived over 200
days, just like MV-infected CD46+ immunocompetent mice.
All mice in this later group were clinically normal. No virus
had replicated judging from the RNA, and protein studies at
the time of sacrifice (40 to 200 days). Correspondingly, MV
failed to replicate in Rag1−/− mice that lacked the CD46 MV
receptor. In contrast, as shown in Fig. 1, MV RNA and protein
were routinely observed in CD46+ × Rag−/− infected mice.
These studies indicated, first, that the mouse immune system
aborted MV replication; i.e., only mice deficient in B and T
cells were unable to control the viral infection. Second, this
system constituted a robust model for studying the effect of
deleting and reconstituting specific lymphocyte subsets alone
or in combination to determine the immune effector(s) and
their molecules that control MV replication and clear MV.
To do these studies, we utilized CD46+ mice and gene
disrupted ko mice in which the CD4, CD8 or B lymphocyte
population was removed or effector molecules of perforin, IFN-
γ or TNF-α were genetically deleted. These studies were
complemented by others in which CD46+ × Rag1−/−mice were
reconstituted with individually purified lymphocyte populations
(purity >94%) alone or in several combinations. All mice
received 1 × 105 PFU of MV i.c., and adoptive transfers
routinely contained either 2 × 107 (twice the amount needed to
clear MV infection) (Fig. 1, panel C) or 5 × 107 lymphocytes
given intraperitoneally (i.p.) 3 days before or after MV
inoculation. Results were equivalent with both doses of
adoptively transferred cells given at 3 days before or after
virus inoculation. As displayed in Fig. 2, after adoptive transfer
of 5 × 107 (upper panels) or 1 × 107 splenic lymphocytes (lower
panels), CD4 and CD8 T lymphocytes obtained from
CD46+ × Rag1−/− mice 110 days after MV inoculation made
significant amounts of IFN-γ (data shown) and TNF-α (data not
shown) indicating the activation of these cells during MV
infection. These results were observed in all of the 5 mice
studied. As anticipated, all mice reconstituted with total splenic
lymphocytes cleared MV infection. In all remaining studies, a
Fig. 1. Model used to define MV immunity. (A) Displays the numbers and groups of adult mice initially used to show the importance of immune control over MV
infection. CD46+ × Rag1+/+, CD46− × Rag1+/+, CD46− × Rag1−/− mice given adoptive transfers of 5 × 107 splenic lymphocytes did not allow MV to replicate or
develop disease. In contrast, virus replication and disease occurred in MV-infected CD46+ × Rag1−/− mice. The Northern blot shows MV RNA in brains of 3 MV-
infected CD46+ × Rag1−/− mice sacrificed at 30, 58 and 80 days, respectively (lanes 2, 5, 6) after inoculation with MV as well as 3 mice (lanes 3, 4, 7) similarly
inoculated with MV but receiving an adoptive transfer of splenic lymphocytes. Lane 1 shows RNA size markers, and lane 9 shows expression of MV nucleoprotein (60
kDa). Lane 8 is a negative control. On the right are MV antigens expressed in neurons in the different experimental groups. Details as to Northern blotting and
immunochemistry are given in Materials and methods. (B) Shows the kinetics of MV-induced disease in CD46+ × Rag1−/− mice and immune protection afforded by
adoptive transfer of 5 × 107 splenic lymphocytes. Note that MV-infected CD46+ mice with competent immune systems are disease free. (C) Illustrates that 5 × 107 or
1 × 107 splenic lymphocytes given (D) but not 5 × 106 splenic lymphocytes adoptively transferred 3 days before MV infection provides complete protection from
infection. (D) illustrates that 5 × 107 splenic lymphocytes adoptively transferred 3 days before or 3 or 10 days after MV challenge are protective. However, 5 × 107
lymphocytes given 20 days after initiation of MV infection are not. Similar results were seen with adoptive transfer of 1 × 107 splenic lymphocytes.
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transfers into CD46+ × Rag1−/− MV-infected mice.
Only CD4 T cells with B cells or CD4 T cells with CD8 T cells
terminate the virus infection. In contrast, CD4, CD8 or B cells
alone, or CD8 T cells with B cells fail to clear the virus
infection
For the initial experiments YAC-CD46 transgenic mice
were crossed and back-crossed with mice genetically
deficient in either CD4, CD8 or B lymphocytes to
specifically delete these cellular subsets from the MV-
receptor bearing mice. When YAC-CD46 mice (8 mice/group) devoid of CD4, CD8 or B lymphocytes were
infected with MV, all lived for over 150 days. When
sacrificed, none showed evidence of MV replication in their
CNS (data not shown). For the next experiments, 2 × 107
splenic CD4, CD8 or B cells were adoptively transferred
into CD46+ × Rag1−/− transgenic mice 3 days before they
were inoculated with MV. As shown in Fig. 3, none of the
adoptively transferred lymphocyte subsets controlled the
spread of MV infection or prevented MV replication in the
CNS. The mean times of death following CD8 T cell
transfer was 61 ± 5 days (10 mice, P =< 0.04) and for CD4
T cell transfer 69 ± 6 days (9 mice, P =< 0.003) as
compared to 47 ± 6 days for mice not receiving a cell
Fig. 2. Intracellular cytokine staining of IFN-γ in CD4 and CD8 T cells obtained from MV-inoculated CD46+ × Rag1−/− mice 110 days after adoptive transfer of
5 × 107 splenic lymphocytes (upper series of panels) or of 1 × 107 splenic lymphocytes (lower set of panels). For both series of panels, expression of IFN-γ (right upper
box) is seen in CD4 and CD8 T cells harvested from 2 individual mice after treatment only with antibody to CD3. For comparison, IFN-γ expressing, virus-specific
CD4 and CD8 T cells harvested 7 days after an acute i.p. challenge with 1 × 105 PFU of lymphocytic choriomeningitis virus (LCMV) ARM 53b are shown. Results
were similar in 3 other CD46+ × Rag1−/− mice receiving adoptive transfers of either 5 × 107 or 1 × 107 splenic lymphocytes. Transfer of splenic lymphocytes into
CD46+ × Rag1−/− mice not inoculated with MV showed negligible to no IFN-γ expression. This experiment was repeated once with equivalent results. Numbers in
the upper right box indicate % of lymphocytes expressing IFN-γ in their cytoplasms.
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Fig. 3. Transfer of 1 × 107 CD4 T cells together with either 1 × 107 B cells or
1 × 107 CD8 T cells provides protection from MV infection. The P value of
reconstituting CD4 T cells with B cells or of CD4 T cells with CD8 cells was
<0.001 when compared to CD46+ × Rag1−/− mice also infected with MV but
not given a supplemental cell transfer. The P value was equivalent when
compared to CD46+ × Rag1−/− mice given adoptive transfers of 2 × 107 whole
splenic lymphocytes. In contrast, adoptive transfer of only 2 × 107 CD8 T cells,
or only 2 × 107 CD4 T cells or only 2 × 107 B cells failed to protect
CD46+ × Rag1−/− mice from MV infection. Similarly, adoptive transfer of
1 × 107 CD8 T cells together with 1 × 107 B cells also failed to protect
CD46+ × Rag1−/− mice from death after MV infection. ● record values for
individual mice in each group; the bar indicates a mean value.
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occurred at 50 ± 6 days in CD46+ × Rag1−/− mice (9 mice,
P = 0.4), a survival time that did not differ significantly
from that of CD46+ × Rag1−/− mice similarly injected with
MV but not receiving an adoptive transfer of splenic
lymphocytes.
We next transferred 1 × 107 CD4 T cells with 1 × 107 B
cells into 8 CD46+ × Rag1−/− mice. Of 8 such mice, 7 (88%)
survived MV infection (Fig. 3) and cleared MV from their
CNS (Fig. 4). The survivors generated high titers of
neutralizing antibodies (Fig. 5A); for 5 mice, the mean value
was 50% neutralization at a serum dilution of 1/65 ± 9 (range
1/30 to 1/79). This value was equivalent to that observed in
mice receiving an adoptive transfer of 5 × 107 splenic
lymphocytes. Further, CD4 T cells harvested from 4 of these
mice 112 days post-MV infection generated IFN-γ (Fig. 5B).
Negligible CD8 T cells were present and negligible IFN-γ was
generated from such cells (Fig. 5B). These results indicated,
first, that CD8 T cell contamination was negligible in the CD4
T and B adoptively transferred cells and, second, that the few
contaminating CD8 T cells present made minimal IFN-γ.
Third, the CD4 T cells made a significant amount of IFN-γ
and, fourth, high titers of neutralizing antibodies were
produced. The mean day of death following CD4 T + B celltransfer was 128 ± 3 days after MV infection (8 mice); when
compared to the lifespan of CD46+ × Rag1−/− mice infected
with MV but not receiving a lymphocyte transfer (18 mice) of
46 ± 3 days (Figs. 3 and 4). This time interval was significant
at a P value of <0.001.
Immune protection and clearance of MV were also observed
when CD46+ × Rag1−/− mice received 1 × 107 CD4 cells with
1 × 107 CD8 T cells. Of 7 mice studied, 5 (71%) survived MV
infection (Figs. 3 and 4) and all of these had no MVantigens in
their CNS (Fig. 4). Additionally, their CD8 and CD4 T
lymphocytes expressed IFN-γ and TNF-α (data not shown).
The two mice that died at days 58 and 90 displayed rampant MV
infection in their neurons. For recipients of CD8 with CD4 T
cell transfers, the mean time to death following MV infection
was 114 ± 11 days as compared to 46 ± 3 days for mice that did
not receive such cells, 61 ± 5 days for mice receiving just CD8 T
cells and 69 ± 6 days for mice receiving just CD4 T cells,
P =< 0.001.
Since CD8 T cells have been reported (Heit et al., 2004) to
prime B cells, we asked if adoptive transfer of 1 × 107 CD8 T
cells with 1 × 107 B cells would protect CD46+ × Rag1−/−mice
from MV infection and clear MV from the CNS in association
with their production of anti-MVantibodies. As shown in Fig. 3,
10 mice receiving such adoptive transfers all died at 47 ± 5 days
following MV infection; all expressed MV antigens in their
brains (Fig. 4), and no neutralizing antibody to MV was present
(Fig. 5A). Thus, CD8 T cells combined with B cells but in the
absence of CD4 T cells had no effect on clearance of MV and
CD8 Tcells were unable to prime B cells to produce antibody to
MV.
IFN-γ, but neither TNF-α nor perforin, plays a role in
clearance of MV
Previous studies (Dhib-Jalbut and Jacobson, 1994; Slifka et
al., 2003; UytdeHaag et al., 1994; Weidinger et al., 2000)
showed that CD8 and CD4 T cells harvested from MV-infected
or MV-immune individuals lysed syngeneic MV-infected target
cells in vitro as well as making IFN-γ and TNF-α. To
distinguish among various effector molecules of these lytic
and non-lytic pathways in our CD46+ model, we adoptively
transferred into CD46+ × Rag1−/− mice 2 × 107 syngeneic
splenic lymphocytes from either perforin ko, TNF-α ko or IFN-
γ ko mice. Reconstitution with lymphocytes deficient either in
perforin (9 mice) or in TNF-α (7 mice) resulted in the same
survival times (Fig. 6A) and cleared MVantigens as well as did
adoptive transfer of perforin and TNF-α sufficient lymphocytes
indicating that neither of these molecules alone played a role in
clearance of MV from the CNS. By contrast, reconstitution with
lymphocytes from IFN-γ ko mice resulted in 5 of 9 mice (56%)
surviving for 130 days after MV infection, the experiment's cut-
off. The 4 mice that died did so 69, 83, 104 and 113 days after
MV infection, a mean of 108 ± 9 days as compared to day 130
for mice receiving lymphocytes deficient in perforin or TNF-α
or normal splenocytes, P = <0.018. However, brain tissue
available from all CD46+ × Rag1−/− mice reconstituted with
IFN-γ deleted lymphocytes, including 5 that were healthy when
Fig. 4. No MVantigen is present in neurons of CD46+ × Rag1−/− mice receiving 1 × 107 CD4 T cells together with 1 × 107 B cells or receiving 1 × 107 CD4 T cells
together with 1 × 107 CD8 T cells. In contrast, CD46+ × Rag1−/− mice infected with MV but not receiving adoptive transfer of splenic lymphocytes or receiving
1 × 107 CD8 T cells along with 1 × 107 B cells express MV in neurons throughout the cerebral cortex (upper panels, immunochemical analysis) or hippocampus (lower
panels). For details as to immunohistochemistry procedure and MV-specific antibody used to detect MVantigens, see Materials and methods. Panel on the left displays
the accumulated mortality and mean ± SD for time of death in these experimental groups.
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replication in their CNS by immunocytochemistry (Fig. 6B),
northern and RT-PCR (data not shown). Thus, no evidence was
found to support a role for a CD4 or CD8 T cell lytic (perforin)
pathway or for TNF-α alone. In contrast, production of IFN-γ
by CD4 and CD8 T lymphocytes was associated with protection
from MVand without IFN-γ, mice became persistently infected
with MV.
In the last experiment, when CD46 × Rag1−/− mice
received 2 × 107 syngeneic splenic lymphocytes from mice
with gene disruption of both IFN-γ and TNF-α, only one of
nine so injected mice survived to day 100 post-MV
inoculation and this mouse displayed MV antigens in its
CNS. For this group of mice death occurred at day 58 ± 6
days. Thus, in control of MV infection of the CNS, while
TNF-α alone has no effect (7/7 mice genetically deficient in
TNF-α control MV replication) and IFN-γ has an effect (5/9
mice genetically deficient in IFN-γ do not succumb to MV
infection but become persistently infected with the virus),
genetic removal of both TNF-α and IFN-γ fails to control
viral replication and results in death, P < 0.001.
Discussion
This paper defines the specific molecules and cells of the
immune system that control MV infection of the CNS. This was
accomplished using a transgenic model in which mice express
the MV receptor, CD46, under transcriptional control of its
authentic promoter (Oldstone et al., 1999). Such CD46+ mice
were manipulated to be devoid of or reconstituted with specificT and B cell components of the adoptive immune response in
conjunction with MV infection. From this study, four main
points emerged. First, a decisive role for the adoptive immune
response in protecting adult YAC-CD46 transgenic mice from
MV infection was confirmed after depleting T and B cells by
placing the YAC-CD46 mice which are fully resistant to MV, on
a Rag1−/− background. Second and most important, CD4 T
cells were shown to play a major role in protection from MV
infection. However, in our system CD4 T cells do not act
independently in control of MV infection as reported earlier for
MV (Finke and Liebert, 1994) and for murine gammaherpes-
virus (Sparks-Thissen et al., 2005). Instead, CD4 T cells in
conjunction with B cells or with CD8 T cells are required to
abort acute MV infection in the vast majority of MV infected
mice. Neither CD4 nor CD8 nor B cells alone were effective.
These results indicate that control of MV is dependent on
multiple lymphocyte subsets and not on a single lymphocyte
subset. Third, mechanistically, IFN-γ but neither perforin nor
TNF-α alone was important in control of MV. Fourth, in the
absence of IFN-γ, MV establishes a persistent infection.
There are now two known receptors for MV, CD46, a
member of the complement regulatory cascade of proteins
(Dorig et al., 1993; Manchester et al., 1994; Naniche et al.,
1993) and signaling lymphocyte activation molecule
(SLAM) (Hsu et al., 2001; Ono et al., 2001; Tatsuo et al.,
2000). Both bind clinical isolates of MV although SLAM is
a high affinity receptor for such wild-type isolates
(Manchester et al., 2000; Oldstone et al., 2002). However,
the CD46 molecule is ubiquitously expressed on all
nucleated cells including neurons, while SLAM has not
240 A. Tishon et al. / Virology 347 (2006) 234–245been found in or on neurons but is expressed on immature
thymocytes, activated and memory T and B cells, and
activated macrophages and dendritic cells. Since the target
cells for MV infection in our tg mouse model was neurons(Oldstone et al., 1999), we elected to use CD46 tgs for our
studies on spread and control of MV infection. The
Edmonston vaccine strain was used because it is well
characterized, its genome can be manipulated by reverse
Fig. 6. (A) Neither perforin nor TNF-α offer protection from MV infection, but IFN-γ does. However, the combination of TNF-α and IFN-γ affords better protection
than IFN-γ alone. The ● represents individual CD46+ × Rag1−/− mice that received, first, 2 × 107 lymphocytes from either perforin-, TNF-α-, or IFN-γ-deficient
mice, and 3 days later a 1 × 105 PFUMV challenge. Other CD46+ × Rag1−/−mice received either an adoptive transfer of 2 × 107 splenic lymphocytes or nothing else.
The bar indicates a mean for each experimental group. (B) Expression of MVantigens in neurons of CD46+ × Rag1−/−mice adoptively transferred with 2 × 107 splenic
lymphocytes from IFN-γ-deficient mice (displayed above in A). The upper panels and lower panel on the left and center depicts results of the 3 CD46+ × Rag1−/−mice
that received 2 × 107 splenic lymphocytes deficient in IFN-γ and survived (until sacrificed) at 130 days. All showed replication of MV in their neurons. The upper
panels are from the same mouse: on the left is the anatomy of nuclei of the thalamus; the center and right represent replication of MV in these nuclei. The lower panels
are from the cerebral cortex. The lower panel on the right exemplifies a mouse dying at 69 days after receiving the IFN-γ-deficient lymphocyte transfer. For the
immunochemical procedure, we used specific antibody to MV, as detailed in Materials and methods.
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to relatively high titers (Oldstone et al., 1999; Patterson et
al., 2001). In contrast, wild-type MV which is primarily cellFig. 5. (A) Generation of neutralizing antibodies to MV in CD46+ × Rag1−/−mice ado
absence of neutralizing antibodies in mice adoptively transferred with 1 × 107 CD4 +
adoptive transfer of CD4 T and B cells or of CD4 and CD8 T cells. Pools from 2 mice
mixed with 600 PFU of MV for 30 min at 37 °C, followed by 15 min on ice and then
input virus treated similarly with sera from mice either without an adoptive transfer o
from such control mice and from recipients of CD4 + CD8 T cells had no reduction o
cell + B cell transfer had significantly reduced titers at 1/20 and 1/50 dilutions. Sim
experiment yielded equivalent results. (B) CD4 lymphocytes were harvested from t
above). These lymphocytes generated IFN-γ in their cytoplasm when treated with an
T + B cell transferred population; almost no IFN-γ was made. The primary LCMV res
bottom line for comparison.associated grows to very low titers unless it is passaged and
selected for in marmoset cells (Kobune et al., 1990;
Manchester et al., 2000).ptively transferred with 1 × 107 CD4 Tcells together with 1 × 107 B cells and the
1 × 107 CD8 T cells. Sera were obtained from 4 individual mice 112 days after
each were diluted in tissue culture media containing 7% heated (37 °C/1 h) FCS,
placed on confluent Vero cells to determine residual PFU of MVas compared to
f lymphocytes or sera from mice prior to receiving the lymphocyte transfer. Sera
f MV plaques at 1/10 dilution. In contrast, sera from mice receiving the CD4 T
ilar results were seen with pooled sera from a second group of mice. A repeat
he same CD46+ × Rag1−/− mice that generated neutralizing antibodies (see A
tibody to CD3. A negligible contamination with CD8 T cells found in the CD4
ponse 7 days (D7 po) after inoculation of 1 × 105 PFU of LCMV is shown on the
2 McGavern, D. and M.B.A. Oldstone. Unpublished observations, 2006.
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contrast, CD46+ × Rag1−/− hosts are completely susceptible.
Susceptibility was reversed by restoration of T and B cells
through transfer of mature naïve spleen cells given 3 days
before or 3 or 10 days after MV challenge. Transfer of 5 or
1 × 107 total splenocytes effectively provided protection and
cleared virus, but 5 × 106 of similar adoptively transferred cells
could not. Rall's laboratory (Lawrence et al., 1999; Patterson et
al., 2002) first reported that adult CD46 transgenic mice were
resistant to MV infection until depletion of T and B cells made
them susceptible. Their results and ours indicate that the
immune response is critical in protecting mice from MV
infection and differ from outcomes in other models using
newborn or suckling mice (Liebert and Finke, 1995) where
susceptibility of immature neurons to virus is the deciding factor
(Fazakerley, 2004). However, there are important differences,
mechanism(s) unknown, between our model described here and
Rall's (Lawrence et al., 1999; Patterson et al., 2002) whose
transgenic mice express the CD46 molecule only in neurons
using the neuron-specific enolase (NSE) promoter. First, our
YAC-CD46+ × Rag1−/− mice inoculated with MV have a
chronic infection with a subsequent mean time of morbidity
leading to death at 48 ± 4 days. In contrast, the mean time of
death for the NSE-CD46 × Rag2−/− mice is significantly
shorter, occurring 12 days after MV infection. Second, with the
NSE-CD46 model, genetically deleting T cell subsets led to
death of 59% for CD4-deficient mice and 41% for CD8-
deficient mice by 19 days post-MV infection, yet our mice with
similar deficiencies in CD4 or CD8 T cells had no MV related
deaths or disease. In fact, they remained healthy throughout a
>150 day observation period. In support of our findings,
adoptive transfer of either CD4, CD8 or B cells alone into our
CD46+ × Rag1−/− mice did not terminate the MV infection.
Our studies clearly show that only the combination of either
CD4 T cells with CD8 T cells or CD4 T cells with B cells are
effective and efficient in clearing acute MV infection of the
CNS. In Rhesus monkeys, experimentally induced MV
infection leads to a vigorous CD4 and CD8 T cell response
(van Binnendijk et al., 1994; Zhu et al., 1997). Ablation of the
CD8 T cell response results in higher virus loads at the peak of
virus replication and a longer duration of viremia (Permar et al.,
2003), however depletion of CD4 T cells has yet to be done so
its effect is unknown.
Mechanistically, we could determine the molecule(s) made
by lymphocytes that aborted MV infection of the CNS.
Although in our tg mouse model antibodies to MV were
generated when CD4 T cells combined with B cells were
adoptively transferred, antibodies appeared not necessary for
MV clearance, since T cells alone without B cells were
sufficient.
CD4 T cells also provide help for B cells (Paul, 1989)
promoting their differentiation into plasma cells and production
of antibody. Antibody is efficient in stopping the spread of MV
in the fluid phase but is ineffective, even with complement, in
killing cells infected with the virus (Sissons et al., 1980). After
we adoptively transferred B and CD4 lymphocytes or whole
splenic lymphocytes into recipient mice they producedneutralizing antibody, i.e., 50% neutralization at a 1/65 ± 9
(range 1/30 to 1/79) or 1/49 ± 20 (range 1/10 to 1/200) dilution
of serum, respectively, after a single MV challenge. Earlier we
found that during a persistent MV infection in immunocompe-
tent YAC-CD46 mice (Oldstone et al., 2005) high titers of
neutralizing MV antibodies are generated (3- to 4-fold higher
than seen with CD4++B cell transfer). These high titers arose
during persistent MV infection presumably due to continuous
stimulation of the immune system with MV antigens. Yet
despite an abundance of neutralizing antibodies, the virus was
not cleared but persisted (Oldstone et al., 2005), indicating that
as in CD46+ × Rag1−/− model presented here, antibodies are
likely not the deciding event in clearance of MV infection. A
similar conclusion that humoral antibody supplies a limited
contribution to clearance of MV came from studies of Rhesus
monkeys (Permar et al., 2004). Thus, results from all three
dissimilar models suggest that antibody to MV may be helpful
but is not essential in control of MV infection and reflect the
findings in humans naturally infected with MV (reviewed
(Burnet, 1968; Good and Zak, 1956; Whitton and Oldstone,
2001).
We next turned our attention to a possible role of lytic
activity of CD8 or CD4 T cells. Earlier, both CD4 and CD8 T
cells obtained from humans were shown to have a lytic activity
against MV-infected cells (Dhib-Jalbut and Jacobson, 1994;
UytdeHaag et al., 1994). While T cell mediated lysis likely
occurs in the periphery, it is an unlikely event in the CNS where
neurons are infected with MV. First, healthy neurons or the vast
majority of neurons infected by any of several viruses, including
MV, fail to express either MHC class I or II molecules on their
plasma membranes (Joly and Oldstone, 1992; Joly et al., 1991;
Kimura and Griffin, 2000; Oldstone, 2004; Redwine et al.,
2001) even when bathed in vivo with IFN-γ (Horwitz et al.,
1999) unless the neurons are electrically inactivated (Medana et
al., 2000; Neumann et al., 1995). Hence, for over 1,000 MV-
infected neurons in cortex, hippocampus and cerebellum
studied in CD46 × Rag1−/− tg mice, none displayed either
MHC class I or MHC class II molecules.2 Neurons are also
deficient in the ability to load peptides onto MHC class I
molecules (Joly and Oldstone, 1992) and thus are unable to
present viral peptide antigens for T cell recognition. Further,
using genetic manipulation to place MHC class I molecules on
the plasma membrane of virally infected neurons (Rall et al.,
1995) did not lead to T cell lysis of neurons, suggesting that
neurons may have evolved an active process to protect
themselves against T cell lytic assault. In support of this
hypothesis, Hendricks and associates (Prabhakaran et al., 2005)
have presented evidence that the Qa-1 component of MHC
molecules in neurons selectively inhibits lytic granule exocy-
tosis by virus-specific cytotoxic T lymphocytes (CTL). Further,
our finding that splenic lymphocytes devoid of perforin, which
is the effector molecule required for CTL killing (Kagi et al.,
1995; Walsh et al., 1994), clear MV infection as well as perforin
+/+ in the absence of histopathologic evidence of neuronal lysis
or significant neuronal drop-out support the contention that
243A. Tishon et al. / Virology 347 (2006) 234–245control of MV infection in the CNS does not proceed through a
T cell lytic pathway.
Although lysis is not the means of clearing MV from infected
neurons, IFN-γ is. For example, splenocytes devoid of IFN-γ
activity were unable to terminate MV infection. Further, when
immunocompetent lymphocytes that controlled MV infection
after adoptive transfer were subsequently isolated and assayed,
both CD8 and CD4 T cells were found to make IFN-γ (Fig. 2).
Such lymphocytes made TNF-α as well. However, when MV-
infected CD46+ × Rag1−/− mice were given transfers of
lymphocytes genetically deficient in TNF-α, MV infection still
resolved indicating that TNF-α, per se, was not required.
Both CD4 and CD8 T lymphocytes produced IFN-γ, and
IFN-γ was required to abort the MV infection. Presumably CD8
lymphocytes alone or CD4 lymphocytes alone were unable to
produce enough of this cytokine to control MV infection even
when 5 × 107 lymphocytes from IFN-γ-competent mice had
been adoptively transferred into MV-infected mice. However,
with this therapy there was a significant delay of death due to
MV infection (Fig. 3), indicating that an additional factor(s) was
required. One possible reason may be the need for CD4 T cells
to provide help to maintain CD8 T cell activity (Matloubian et
al., 1994; Tishon et al., 1995). Another factor may be that
during MV infection in the CD46 tg model, primarily CD4 T
cells and to a lesser extent CD8 T cells are quantitatively
depressed in their ability to make IFN-γ (Slifka et al., 2003).
In conclusion, our results indicate that CD4 T cells play a
pivotal role in control of primary MV infection of the CNS.
CD4 T cells achieve this not independently but by interacting
with either CD8 T cells or B cells. IFN-γ is shown to be an
important molecule in the clearance of MV from the CNS
although it is unknown if its activity reflects direct action on
infected neurons or by modulation of immune cells or both. This
clearing effect of IFN-γ on virally infected neurons has also
been observed with lymphocytic choriomeningitis virus
infection of neurons (Tishon et al., 1995) and with γ herpes
virus infection (Sparks-Thissen et al., 2005). It will be important
to determine if this is a common theme and whether IFN-γ
deficiency may play a significant role in establishment of
persistent infections with other viruses. Lastly, the model
presented here should be of value in determining the correlates
of protection against secondary measles virus infection through
the adoptive transfer of memory (immune) CD4 Tand/or CD8 T




Generation and characterization of YAC-CD46 transgenic
mice before and after infection with MV Edmonston (Ed) strain
have been described (Oldstone et al., 1999; Patterson et al.,
2001; Slifka et al., 2003). YAC-CD46 mice are on the C57Bl/6
background. The mice were crossed to Rag1−/− mice, also on a
C57Bl/6 background to yield a YAC-CD46+ × Rag1−/− mouse
(Patterson et al., 2001). These mice as well as Rag1−/− andYAC-CD46 were used for all experiments. YAC-CD46 were
also crossed to CD8−/−, CD4−/−, B cell−/−, perforin−/−, TNF-
α−/− and interferon-γ−/− mice also on the C57Bl/6 back-
ground. All mice were obtained from The Scripps Research
Institute rodent breeding colony. Expression or lack of
expression of CD46, Rag, perforin, TNF-α and interferon-γ
was verified in all mice used by screening DNA obtained from
tail biopsies and PCR reactions as described (Horwitz et al.,
1999; Kagi et al., 1995; Oldstone et al., 1999; Tishon et al.,
1995). Presence or absence of CD8, CD4 or B cells was
determined using monospecific antibodies to these various
lymphocyte preparations and FACS as described (Homann et
al., 2001; Tishon et al., 1995).
MV used was the Ed strain. MV seed stock was prepared by
low-multiplicity infection of Vero cells, harvested as super-
natants after disruption of infected cells. Cellular debris was
removed by low-speed centrifugation and resultant virus stock
was placed in 1 ml aliquots and stored at −70 °C. Virus was
titered on Vero cells. PFU dose of 1 × 105 was given
intracerebrally (i.c.) to mice. Earlier studies indicated that
intranasal inoculation of MV also resulted in CNS infection of
neurons in CD46+ × Rag1−/− mice (Oldstone et al., 1999;
Patterson et al., 2001). For ease in experiments the i.c. route was
used.
Purification of various lymphocyte populations and their use in
adoptive transfer studies
Single cell suspension from spleens of C57Bl/6 (H-2 mice)
cleared of RBC was isolated using Stem-Sep kit (Stem Cell
Technologies, Vancouver, BC, Canada) to enrich for CD4, CD8
and B lymphocytes. Purity after column purification exceeded
95% as determined by FACS analysis using specific monoclo-
nal antibodies to the various lymphocyte subsets (Homann et
al., 2001; Tishon et al., 1995).
Such purified CD4, CD8 or B cells at a concentration of 1 or
2 × 107 cells were adoptively transferred i.p. into YAC-
CD46+ × Rag1−/− recipient mice. Similarly, 5 × 106, 1 × 107, or
5 × 107 of splenic lymphocytes, cleared of RBC and obtained
from normal adult C57Bl/6 mice or mice in which the perforin
or TNF-α or interferon-γ genes was knocked out was similarly
transferred into YAC-CD46 × Rag1−/−mice. Depending on the
experimental protocol, transfer occurred 3 days before or 3, 10,
or 20 days after MV inoculation.
Immunohistochemical, Northern blot and RT-PCR analysis of
MV replication
Brains were harvested from mice at various times post-
infection, fixed with 4% paraformaldehyde, and cut into 40 μm
sections in a vibratome. Sections were blocked with normal goat
serum, biotin, and streptavidin (Vector Laboratories, Burlin-
game, CA) added as described (Oldstone et al., 1999; Patterson
et al., 2001). Anti-MV antibody was a human polyclonal
antiserum from an SSPE patient and was previously shown to
recognize MV antigens (Oldstone et al., 1999; Patterson et al.,
2001).
244 A. Tishon et al. / Virology 347 (2006) 234–245For Northern analysis at the time of sacrifice or death,
brains were removed and divided along the midline. One
hemisphere was immediately frozen in liquid nitrogen,
whereas the other half was frozen in OCT compound on dry
ice for preparing cryostat sections. RNA was isolated from
fresh-frozen brains using Tri-reagent (Molecular Research
Center, Cincinnati, OH). Total RNA (7 μg/sample) was
electrophoresed through a 0.8% agarose-formaldehyde gel
and transferred to a Nytran membrane (Micron Separations,
Westborough, MA). For detection of MV RNA, an MV-
nucleoprotein (N) probe was prepared by random-primer
labeling of the 375-nt NsiI/XbaI cDNA fragment from the MV
N-gene (plasmid peN1). Blots were probed with a random-
primed, 32P-radiolabeled DNA probe for MV N RNA or the
entire cDNA for MV, p(+)MV deleted of N, by hybridizing at
65 °C in QuickHyb (Stratagene, La Jolla, CA) for 3 h. As
controls, the blots were also similarly probed with the 609-nt
32P-radiolabeled EcoRI fragment of the rat glyceraldehyde-6-
phosphate dehydrogenase (GAPDH) housekeeping gene. Blots
were washed at high stringency with 0.2× SSC/0.1% SDS at
65 °C.
RT-PCR amplification of MV RNA was carried out using
MV N gene specific primers 5′-GGCCACACTTTTAAG-
GAGCTTAGC-3′ and 5′-GGGCCGTAACCGCCTTTGCG-
3′, -5′, and -3′ relative to the N mRNA, respectively. The 554
nt N fragment was generated using standard conditions with Taq
polymerase (Boehringer Mannheim, Germany) and 40 cycles of
amplification.
Detection of neutralizing antibody
Stock MV was diluted to 600 PFU and mixed with sera
obtained prior to MV inoculation or sera obtained at time of
sacrifice from MV-inoculated mice. Post-MV challenge sera
was heat inactivated at 56 °C for 30 min and then diluted 1/10,
1/20, 1/50, 1/100, 1/200, 1/500 and mixed with 600 PFU of
input virus. After a 30-min incubation at 37 °C the mixture was
placed for 10 min. on ice prior to being added to 6-well Petri
dishes containing adherent Vero cells. After a 60-min
incubation period, 1% agar in RPMI media containing 7%
heat-inactivated fetal calf serum was added, plates placed in a
CO2 incubator and followed daily for the formation of syncytia.
Plates were fixed and plaques counted as described (Oldstone et
al., 1999).
Detection of interferon-γ and TNF-α in cytosol of lymphocytes
harvested from MV-infected mice
Single cell suspensions obtained from the spleen were
stimulated for 5 h at 37 °C with 1 mg/ml of a 1/100 dilution of
antibody to CD3 in the presence of 100 μg/ml of IL-2, 4 μg/ml
of Brefeldin-A and 2 μg/ml of antibody to CD28 as described
(Homann et al., 2001). Staining of cell surface antigen (CD4 or
CD8) and intracellular antigens done as published (Homann et
al., 2001). Negative controls were cells harvested from
uninfected mice or from CD46nil mice receiving lymphocytes
or various lymphocyte subsets. Positive control consisted oflymphocytes from CD46+ mice 7 days after receiving
1 × 105 PFU of LCMV ARM i.p. (Tishon et al., 1995). Cells
were acquired with FACSort or FACScalibur flow cytometers
(Becktin Dickinson, San Jose, CA) using Cell Quest software
(Becktin Dickinson).
Statistical analyses
Data handling, analysis and graphic representation was
performed using Prism 2.01 (GraphPad Software, San Diego,
CA).
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